IQVIA Holdings Inc. (IQV) Guidance & Earnings Results

On 2026-07-28 IQVIA Holdings Inc. raised guidance: "Revenue guidance raised to $17,275M-$17,475M (mid-point 6.5% growth vs prior 5.8%); Adjusted EBITDA to $4,000M-$4,050M; Adjusted EPS to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IQVIQVIA Holdings Inc.Follow IQV — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 46.0B
P/E TTM: 34.7
Dividend yield: —
52-week: —
Next earnings: 27 Oct, in 3 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
28 Jul 26	Raised	Revenue guidance raised to $17,275M-$17,475M (mid-point 6.5% growth vs prior 5.8%); Adjusted EBITDA to $4,000M-$4,050M; Adjusted EPS to $12.80-$13.00 · full year
5 May 26	Raised	FY2026 Adj. Diluted EPS raised to $12.65-$12.95; revenue reaffirmed $17.15B-$17.35B; Adj. EBITDA reaffirmed $3.975B-$4.025B · full year
5 Feb 26	Raised	FY26 revenue guidance $17.15B-$17.35B vs FY25 $16.31B; Adjusted EBITDA $3.975B-$4.025B vs FY25 $3.788B
28 Oct 25	Reaffirmed	FY2025 revenue $16,150M-$16,250M; Adjusted EBITDA $3,775M-$3,800M; Adjusted EPS $11.85-$11.95 · full year

IQVIA Holdings Inc. — questions

What guidance did IQVIA Holdings Inc. give?: On 2026-07-28: "Revenue guidance raised to $17,275M-$17,475M (mid-point 6.5% growth vs prior 5.8%); Adjusted EBITDA to $4,000M-$4,050M; Adjusted EPS to $12.80-$13.00"
When does IQVIA Holdings Inc. report earnings?: IQVIA Holdings Inc.'s next earnings report is expected on 2026-10-27.

Every figure on this page comes from IQVIA Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.